
Shekaib Rahman Behroz
French Medical Institute for Mothers and Childrenv, AfghanistanTitle: Outcome of one-stage open reduction and salter’s osteotomy for developmental dysplasia of the hip (DDH) after walking age at French medical institute for mothers and children (FMIC), Kabul, Afghanistan
Abstract
Background:
Developmental
Dysplasia of the Hip (DDH) generally includes subluxation or dislocation of
femoral head from acetabulum and acetabular dysplasia. DDH is one of the most
common congenital problems and occurs in newborns with different causes such as
ligamentous laxity, difficult delivery and postnatal positioning. Estimates of
the incidence rate of DDH are 1-2 per 1000 live births. The risk of a second
child being affected in a family with one child with DDH is approximately 10
times that in the general population.
Objective:
The aim of this
study is to determine the outcomes of One-Stage Open Reduction and Salter’s osteotomy
for Developmental Dysplasia of the Hip (DDH) among children at FMIC.
Methodology:
A retrospective
case series study design was employed. The data was collected from the
available records of 150 participants who had undergone One-stage Open
reduction and Salter’s osteotomy procedure at FMIC hospital at the period of
2011 to 2016. Age of participant was 18-36 months. Majority 112(74.6%) of the
participants were female and 38(26.4%) were male. 60participants (40%) had
bilateral DDH, 53(35.3%) had left side and 37(24.7%) were right side. Post
operation follow up age was 34.29 months.
Result:
In this study we
observed excellent result in 123(82%), good in 16(10.6%) fair in 2(1.3%) and
poor result in 9(6.1%) patients. Mean difference of Pre-operation and
Post-Operation Acetabular Index was 18.361±5.004 (P-value 0.000).
Conclusion:
One-stage Open
reduction and Salter’s osteotomy was one of the best and effective treatment
method for developmental dysplasia of the hip after walking age. We strongly support
the use of one-stage open reduction and Salter innominate osteotomy at 18
months to 3 years for the treatment of developmental dysplasia of the hip diagnosed
late or after failure to respond to previous treatment.